About Us

ADA Newsroom

Get the latest news from ADA, including press releases and research announcements.

Senior couple reading news on laptop

Press Releases

If you are looking for ADA press releases issued prior to 2019, please email press@diabetes.org.

Recent Press release

American Diabetes Association logo reversed out white on red background
Local Press Release

Back-to-School Wellness Expo Addresses Health Needs in D.C.’s Ward 8

The Collaboration for Equitable Health with Black Nurses
American Diabetes Association logo reversed out white on red background
Local Press Release

The American Diabetes Association and CareFirst BlueCross BlueShield Join Forces to Focus on Diabetes Prevention and Nutrition Education

The American Diabetes Association ® (ADA) and CareFirst
American Diabetes Association logo reversed out white on red background
Press release

Abbott and the American Diabetes Association Collaborate to Drive a Better Understanding of the Role of Nutrition Formulas to Support People with Diabetes and Obesity

The American Diabetes Association ® (ADA) and Abbott

Official Statement

Recent Press release

American Diabetes Association logo reversed out white on red background
Local Press Release

Back-to-School Wellness Expo Addresses Health Needs in D.C.’s Ward 8

The Collaboration for Equitable Health with Black Nurses
American Diabetes Association logo reversed out white on red background
Local Press Release

The American Diabetes Association and CareFirst BlueCross BlueShield Join Forces to Focus on Diabetes Prevention and Nutrition Education

The American Diabetes Association ® (ADA) and CareFirst
American Diabetes Association logo reversed out white on red background
Press release

Abbott and the American Diabetes Association Collaborate to Drive a Better Understanding of the Role of Nutrition Formulas to Support People with Diabetes and Obesity

The American Diabetes Association ® (ADA) and Abbott
Filter by:
Sort by:
Press release

Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes

The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (…
Published: Monday, June 10, 2019
ada-a_comms_logo
Press release

Linagliptin and Glimepiride Have Comparable Cardiovascular Safety Effects in Type 2 Diabetes at High Cardiovascular Risk

The diabetes medications glimepiride and linagliptin had similar impacts on cardiovascular morbidity and mortality for a median period of…
Published: Monday, June 10, 2019
ada-a_comms_logo

Meet Our Experts

The American Diabetes Association is proud to partner with leading experts in the field of diabetes—each one directed to advancing the treatment and prevention of this disease.

CEO Charles
Charles D. Henderson

Chief Executive Officer

Robert Gabbay
Robert Gabbay, MD, PhD

Chief Scientific and Medical Officer 

Lisa Murdock headshot
Lisa Murdock

Chief Advocacy Officer 

Dr. El Sayed
Nuha El Sayed, MD, MMSc

Senior Vice President, Health Care Improvement 

Marlon Pragnell
Marlon Pragnell, PhD

Vice President, Research & Science 

Crystal Woodward
Crystal Woodward, MPS

Managing Director, Legal Advocacy/Safe at School